Pharmacy Practice NewsWhen Law Enforcement Comes Knocking, Be Prepared

⚖️ Legal / Ethical Complexity

At the National Association of Specialty Pharmacy’s inSPire2026 meeting, legal experts advised specialty pharmacies to prepare for potential inspections, subpoenas, and enforcement actions involving agencies including the DEA, Department of Justice, Office of Inspector General, and state attorneys general. Speakers described an environment of heightened federal focus on fraud, waste, abuse, controlled substances, reimbursement practices, documentation, and medical necessity reviews. Specialty pharmacies may face increased scrutiny because they manage high-cost therapies, complex reimbursement pathways, specialty distribution models, telehealth-related workflows, and, in some cases, controlled substances. The discussion emphasized that enforcement activity often follows identifiable risk signals rather than random selection.

Professional Impact

• Regulatory agencies are increasingly using data analytics to identify potential compliance concerns and operational outliers.
• Unusual dispensing or ordering patterns may attract regulatory attention, particularly when documentation does not adequately explain legitimate clinical circumstances.
• Whistleblower complaints, inventory discrepancies, security gaps, recordkeeping deficiencies, and patient harm events may trigger reviews or investigations.
• Specialty pharmacies face unique exposure due to high-cost medications, complex reimbursement structures, and multiple care-transition handoffs.
• Documentation supporting corresponding responsibility decisions and red-flag evaluations may become important during regulatory review.
• Compliance programs are more defensible when policies, investigations, escalation pathways, and corrective actions are consistently documented.

Action Items

• Review compliance policies regularly to ensure alignment with current enforcement priorities and controlled-substance requirements.
• Document clinical and operational factors that may explain unusual dispensing or utilization patterns.
• Evaluate internal monitoring processes for inventory control, recordkeeping, diversion prevention, and regulatory compliance.
• Train pharmacy personnel on escalation procedures and documentation expectations when concerns arise.
• Audit compliance workflows and corrective-action processes to identify and address vulnerabilities before an inspection occurs.